Jaguar Health gets Nasdaq extension to May 18 for bid-price compliance; delisting risk remains

Jaguar Health, Inc.

Received Nasdaq Staff notice on May 1, 2026 for non-compliance with 500,000 publicly held shares requirement.
Investors exercised pre-funded warrants on May 4, 2026, curing publicly held shares deficiency.
Panel granted one-day extension to May 18, 2026 to show closing bid price >= $1.00 for 10 consecutive days.
Company warns it may not meet the extension terms and could face delisting from Nasdaq.
Non-compliance with bid price rule clock reset after cure of publicly held shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.